GlassScriptPhysician profile
Diane Thaler
NPI 1902868490
$1,518.99
in general payments reported to CMS, 2019-2025
11 companies · $309 in 2025
The $309 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $49.34 · 2021: $140 · 2022: $265 · 2023: $293 · 2024: $304 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $930.25 | 2021-2025 | Dupixent |
| Lilly USA, LLC | $140.50 | 2023-2025 | Taltz, Ebglyss, Olumiant |
| Celgene Corporation | $111.37 | 2019 | |
| Janssen Biotech, INC. | $83.30 | 2022-2023 | Tremfya |
| Ucb, INC. | $50.72 | 2024-2025 | Bimzelx |
| Amgen INC. | $49.34 | 2020 | |
| Abbvie INC. | $44.07 | 2019-2024 | |
| Genzyme Corporation | $36.32 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $32.00 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.62 | 2023 | Spevigo |
| Allergan, INC. | $17.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Thaler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.